4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-055430
President and CEO sold 2,400 shares at $575.34 ($1,380,816)
- President and CEO acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sibold William John President and CEO | 2025-12-03 | Option exercise | +50,000 | 152,474 | D | ||
| Sibold William John President and CEO | 2025-12-04 | Sale | −2,400 | $575.34 | $1,380,816 | 150,074 | D |
| Derivatives | |||||||
| Sibold William John President and CEO | 2025-12-03 | Option exercise · Performance Restricted Stock Units | −50,000 | 0 | D | ||
| Open-market sales · 2,400 sh · avg $575.34 · $1,380,816 | |||||||
Loading xslF345X05/wk-form4_1764887216.xml…